Lyra Medical

Long-term Solution for Pelvic Floor Repair

Health Tech & Life Sciences
Active
Mature Binyamina-Giv'at Ada, Israel Founded 2011
Last updated 2026-06-18
Total raised
Last: 2016-01
Stage
Mature
Founded
2011
Headcount
5
HQ
Binyamina-Giv'at Ada, Israel
Sector
Health Tech & Life Sciences

About

Lyra Medical develops a safe way to implant an organ-support mechanism in women suffering from pelvic organ prolapse. The company's Self-Retaining Support technology is used in the flagship Lyra system for anterior vaginal wall, apex, and uterine prolapse. The support platform may also be applicable in other pelvic organ disorder conditions, including rectocele and urinary incontinence, as well as other clinical areas such as hernias. Lyra Medical has a robust IP portfolio, including approved US and EU patents and pending applications in other regions. Lyra has completed two clinical studies, with a total of 70 patients, showing excellent results. The company is obtaining EU and Israeli regulatory approval (CE mark and AMAR) with a product launch in Israel and strategic EU markets to follow. Lyra has signed an international distribution agreement with an EU-based strategic partner.

Funding history · 1 round · — total

2016-01

Q&A

What is Lyra Medical's primary focus?
Lyra Medical develops a safe way to implant an organ-support mechanism in women suffering from pelvic organ prolapse, with its flagship Lyra system addressing anterior vaginal wall, apex, and uterine prolapse.
What is the current employee count for Lyra Medical?
Lyra Medical has 1-10 employees.
What is Lyra Medical's product stage?
Lyra Medical's product is currently released.
What is Lyra Medical's current stage?
Lyra Medical is currently in the Mature stage.
When was Lyra Medical founded?
Lyra Medical was founded in July 2011.
Has Lyra Medical completed any clinical studies?
Yes, Lyra Medical has completed two clinical studies involving a total of 70 patients, showing excellent results.
What regulatory approvals is Lyra Medical pursuing?
Lyra Medical is obtaining EU and Israeli regulatory approval (CE mark and AMAR).
Does Lyra Medical have an international distribution agreement?
Yes, Lyra Medical has signed an international distribution agreement with an EU-based strategic partner.
What is Lyra Medical's intellectual property status?
Lyra Medical has a robust IP portfolio, including approved US and EU patents and pending applications in other regions.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CMO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersConsumersDemographics & FamilyWomen
Business model
B2B

Highlights

1 PatentsVerified

Tags

women-healthgynecologyurinary-systemhospitalsmedical-devicesdoctorsurologytreatmentsfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitelyramedical.com/
LinkedInlinkedin.com/company/64523066

Identifiers & details

Founded2011-7
Employees (exact)5

Radar intelligence

Patents

EPO2

Web history (Wayback)

Domainlyramedical.com

Certificate / subdomain footprint

Subdomains7